The engineering breakthrough is the way it delivers light. Rather than embedding a light source on the chip itself—which would cook the surrounding tissue—the probe uses an integrated photonic waveguide. An external laser feeds light into the waveguide, which routes it down the shank to the 28 emission sites . This design eliminates the heat and electrical noise that plagued earlier attempts to combine electronics and photonics on the same device.
What emerges is what its creators call a “perturb-and-record” capability: stimulate a genetically defined population of neurons in one cortical layer, and simultaneously record the ripple effects across hundreds of surrounding neurons—and even distant brain regions .
The probe’s first systematic tests in mice, reported in the Nature Methods paper, demonstrated that it could differentially activate or silence neurons at distinct cortical depths . That was expected. What surprised researchers was how far those local perturbations traveled.
In the mouse striatum and other deep brain structures, Neuropixels Opto delivered efficient optotagging—the identification of genetically defined cell types based on their light-driven responses . More importantly, the simultaneous recording across 960 sites revealed that manipulating a local cortical column produced widespread, non-local effects on distant neurons and brain regions
.
Because earlier technologies forced researchers to stimulate with one tool and record with another, these network-level propagation patterns were incredibly difficult to observe. Neuropixels Opto collapses that separation into a single instrument, exposing the true complexity of how a local perturbation cascades through a living brain.
The probe’s ability to reach deep brain structures while simultaneously recording and manipulating specific cell types makes it a powerful tool for studying neurological and psychiatric conditions that are fundamentally circuit-level disorders.
The hippocampus and entorhinal cortex are among the earliest structures affected by Alzheimer’s pathology. Neuropixels Opto’s long shank can reach these deep regions while its light emitters target specific interneuron populations known to be disrupted by amyloid and tau accumulation . By manipulating those cells and recording the network’s response in real time, researchers can build causal models of how pathology degrades circuit function—moving beyond simple correlation.
Parkinson’s is characterized by dopamine neuron loss in the substantia nigra and abnormal firing patterns in the striatum and basal ganglia. Neuropixels Opto can be inserted into the striatum and other deep structures, delivering spatially precise optogenetic stimulation while recording from hundreds of neurons that represent different cell types and circuit pathways . This could help disentangle exactly which cell types drive motor symptoms and how they interact when dopamine signaling fails.
One leading hypothesis for schizophrenia implicates parvalbumin-positive interneurons and their role in generating gamma-frequency oscillations that coordinate cortical networks. Neuropixels Opto can directly activate or silence these genetically labeled interneurons while recording from distributed cortical populations, enabling causal tests of the hypothesis that interneuron dysfunction underlies the disorder’s cognitive and perceptual symptoms .
Rather than simply correlating neural activity with behavior or pathology, researchers can now ask—and answer—questions about what specific cell types actually cause when they malfunction. That shift from correlation to causation is what makes Neuropixels Opto a genuine leap forward for translational neuroscience.
Comments
0 comments